BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

Clinical trial NCT05768932 · RECRUITING

Trial details

NCT number: NCT05768932
Sponsor: SillaJen, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor TNBC - Triple-Negative Breast Cancer Gastric Cancer Leukemia Acute Myeloid Leukemia (AML)

Start date: 2022-12-14
Primary completion: 2026-12-24
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.